3 Takeaways From FDA's Branded Drug User Fee Workshop
The U.S. Food and Drug Administration on Wednesday kicked off discussions over the next round of pharmaceutical industry user fees to support brand-name product approvals, hearing repeated pleas for better communication,...To view the full article, register now.
Already a subscriber? Click here to view full article